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Background: Vitamin D may have a role in many chronic conditions in addition to bone health. Nutritional surveys
among Americans have reported high levels of vitamin D insufficiency, especially among Blacks and Latinos. Our
study examined variation in vitamin D supplementation practices in an adult health plan population by age,
gender, and race-ethnicity.
Methods: Self-report data from a 2008 general health survey in a large Northern California health plan were used
to characterize number and types of sources of vitamin D supplementation (multivitamin, calcium with D, singular
D) among women and men aged 25-85, overall, by race-ethnicity, and for obese, diabetic, and hypertensive
subgroups.
Results: In this population, 40% of women and 54% of men ≤ 50, and 24% of women and 53% of men aged 51-85
get no vitamin D from dietary supplements. Higher vitamin D supplementation among women > 50 is associated
with higher reported intake of calcium with D. Black and Latina women aged 25-85 and Filipinas in the ≤ 50 age
group were significantly less likely than non-Hispanic Whites to get vitamin D from supplements, whereas vitamin
D supplementation practices among Chinese women did not significantly differ from non-Hispanic Whites. Among
men, Latinos aged 25-85 and Black and Chinese ≤ 50 were significantly less likely than non-Hispanic Whites to get
vitamin D from supplements. Similar race-ethnic differences in vitamin D supplementation patterns were observed
for people in the obese, diabetic, and hypertensive groups.
Conclusions: Our survey results suggest that in 2008, a large percentage of women and an even larger percentage
of men in a large Northern California health plan get no vitamin D from dietary supplements, and that Blacks and
Latinos and obese adults, who are at higher risk of vitamin D deficiency, are also the least likely to get any vitamin
D from dietary supplements.
Keywords: Vitamin D supplementation, Multivitamin supplementation, calcium supplementation, differences in
vitamin D supplementation, gender differences in vitamin D supplementationBackground
It is well-accepted that low vitamin D can cause bones to
become brittle and misshapen (rickets) [1]. Further, clin-
ical trials have shown that vitamin D supplementation
can reduce osteoporosis, decrease risk of falls, and impact
all-cause mortality among healthy middle aged and eld-
erly adults [2,3]. Less conclusive and less well studied is
the relationship of low vitamin D to increased risk of a* Correspondence: nancy.gordon@kp.org
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reproduction in any medium, provided the orgrowing number of chronic illnesses (various cancers, dia-
betes, hypertension, heart disease, kidney disease, asthma,
and autoimmune diseases), infectious respiratory diseases,
pregnancy-related problems, and adverse birth outcomes
seen in observational studies [4-29]. Recent clinical re-
search has shown that most tissues and cells in the
human body have a vitamin D receptor, and that several
possess the ability to convert the primary circulating form
of vitamin D, 25-hydroxyvitamin D, to the active form,
1,25-dihydroxyvitamin D [30]. At the genetic level,
researchers have also found over 2,700 binding sites forl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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genome, with unusually large concentrations near a
number of genes associated with autoimmune condi-
tions, certain cancers, and type 1 diabetes. However, in
2010, an Institute of Medicine (IOM) expert panel
reviewed the evidence for adequate intake of vitamin D
and calcium and found no strong cause-and-effect evi-
dence that remediating vitamin D insufficiency would
prevent the development of any conditions other than
osteoporosis [31].
There is evidence that a substantial percentage of the
U.S. population has serum vitamin D concentrations
below the levels currently recommended for people their
age [32,33]. Based on cut-points that define serum 25-
hydroxyvitamin D (25[OH]D) as deficient if <20 ng/mL
and insufficient if 21–29 ng/mL [6], NHANES 2001–
2004 showed that 77% of the U.S. population was vita-
min D insufficient, a significantly higher prevalence than
was seen in the 1994–1998 NHANES [34]. However,
there were striking race-ethnic differences. While ap-
proximately 70% of adult nonHispanic white men and
women were vitamin D insufficient, over 95% of nonHis-
panic Black/African-American men and women and ap-
proximately 90% of Latino men and women had
insufficient vitamin D concentrations [34]. Another
study using NHANES 2004–2006 serum data found that
approximately 42% of U.S. adults were vitamin D defi-
cient, with significantly higher prevalence of deficiency
among Blacks (82%) and Latinos (62%) compared with
nonHispanic Whites (30%) [33]. Studies of well-
characterized populations have also found very high
levels of vitamin D insufficiency and deficiency in the
U.S. population, including Black and Latino adolescents
and adults [35-37], pregnant women [38,39], older
adults [40], obese (BMI ≥ 30) adults [33], hypertensives
[33], and people with low HDL cholesterol [33]. While
the IOM and Endocrine Society recently reaffirmed the
cut-point for vitamin D deficiency as <20 ng/mL
[41,42], many researchers have also started to question
whether this is too low, suggesting that < 32 ng/mL is
a more appropriate cut-point based on an array of bio-
markers that have been show to be adversely affected
by vitamin D deficiency [43,44]. This would obviously
make the prevalence of vitamin D deficiency and insuf-
ficiency in the U.S. population, and especially in high
risk groups, much higher.
Based on a review of evidence, in 2010, the IOM
expert panel on vitamin D increased the recommended
daily allowance (RDA) for vitamin D to 600 IU/day for
children and adults through age 70 and 800 IU/day for
ages 71 and older [41]. Prior to this, the RDA was 200 IU/
day for children and adults through age 50, 400 IU/day for
adults aged 51–70, and 600 IU/day for adults ages 71 and
older [41].Surveillance studies suggest that only a small percent-
age of the U.S. population gets adequate vitamin D from
food sources. According to NHANES 2005–2006, only
10% of adults aged 51–70 and 15% of those aged ≥71
met the AI (average daily intake) for vitamin D from
food based on 1997 dietary reference intake (DRI) criteria
[45]. Further, data from the 1988–1994 and 1999–2000
NHANES show that starting about the time of puberty,
usual vitamin D intake from food of African-Americans is
significantly below that of nonHispanic Whites and
Latinos in every age group, with the exception that DAI
of Latinos drops to the level of African-Americans in
the ≥71 age group [46,47].
Before 2010, when singular D supplements started to
become more widely available, vitamin D was primarily
obtained from daily multivitamins and calcium plus D.
According to NHANES data for 2003–2006, 56% of
women aged ≥60, 45% of women aged 40–59, and 33%
of women aged 20–39 got vitamin D from one or more
dietary supplements, up significantly from 1999–2002.
Vitamin D supplementation among men was signifi-
cantly lower than that of women in the same age groups
(44%, 38%, and 26%, respectively) and had not changed
from the earlier time period [46]. As with vitamin D intake
from food, NHANES data indicated that African-American
and Latina women were significantly less likely to take
calcium and multivitamin supplements than nonHispanic
White women [48-52].
In order to characterize vitamin D supplementation
practices among insured adults in Northern California
and learn whether supplementation practices differ by
race-ethnicity, we analyzed data obtained from the 2008
Kaiser Permanente Northern California (KPNC) adult
Member Health Survey. Our study had two main objec-
tives: (1) to describe vitamin D supplementation prac-
tices of adult men and women in different age groups
and with metabolic conditions that may increase risk
(obesity) or be affected by (diabetes, hypertension) vitamin
D deficiency; and (2) to determine whether vitamin D
supplementation practices vary by race/ethnicity. A
secondary objective was to investigate whether sources




Data for this study come from the 2008 Kaiser Permanente
Northern California (KPNC) Member Health Surveys
(MHS) [53]. This survey is conducted every three years
using a confidential self-administered questionnaire
(hardcopy or link to an online version) sent to an age-,
gender-, and geographically stratified random sample of
KPNC adult members. The KPNC adult population is
highly comparable to the population of insured adults
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health-related characteristics, with the exception of a
smaller percentage of adults at very low levels of income
and education [54]. The MHS collects information
about a variety of member characteristics including
demographics, selected health conditions and overall
health status, and health-related behaviors, including
use of dietary supplements. The survey is funded by
KPNC’s Community Benefit Program and approved by
KPNC’s Institutional Review Board.
Study variables
The MHS dietary supplement question asked “During
the past 12 months, did you use any herbals, nutritional
supplements, or other “natural” remedies to treat or
prevent your own health problems?” Daily multivitamin,
calcium with D, and calcium without D (including Tums
or Rolaids) were included as checklist items, and respon-
dents were also asked to write in additional dietary sup-
plements which were subsequently coded (this latter was
the source of vitamin D alone or as part of another non-
calcium, non-multivitamin supplement). In 2008, a regu-
lar adult multivitamin, calcium with D tablet (calciumD),
and singular vitamin D tablet each usually provided 400
IU of vitamin D2. Based on labeled recommended
dosages, intake of more than one of these supplements
daily would be needed for an individual to get over 400
IU of vitamin D from dietary supplements. Age, gender,
race/ethnicity, education, obesity (BMI ≥ 30), non-
gestational diabetes, and hypertension were also assigned
based on self-reported survey data.
The study sample consisted of all respondents aged
25–85 who provided information about their use of
multivitamin and calcium supplements. There were
8,884 women (3,531 aged 25–50, 3,116 aged 51–70, and
2,237 aged 71–85) and 7,165 men (2,119 aged 25–50,
2,737 aged 51–70, and 2,308 aged 71–85). The numbers
of respondents in the five race/ethnic groups and three
health risk groups can be found in Table 1. Subgroup
comparisons were restricted to these five race/ethnic
groups because of small numbers in other ethnic groups.
Statistical analysis
Because supplementation practices are known to differ
significantly by gender, we conducted all analyses
separately for men and women. To study differences by
age, we first analyzed vitamin D supplementation prac-
tices separately for three age groups (25–50, 51–70,
and 71–85). Because we found no significant differ-
ences in supplementation patterns between the 51–70 and
71–85 age groups, these age groups were combined for
race-ethnic and health risk groups analyses. Race-ethnicity
analyses were restricted to five groups (nonHispanic White,
African-American/Black, Latino/a, Filipino/a, and Chinese)due to sample size, and in the case of obese and diabetic
patients, comparisons omit the Asian groups due to small
numbers.
All analyses used respondent data weighted using a
post-stratification weighting factor that made the final
respondent sample reflect the actual age (by 5-year
intervals), gender and geographic distribution of the
adult membership from which the sample was drawn.
While percentages reported in the text and tables are
based on weighted data, the table Ns are actual
unweighted subgroup denominators used in the ana-
lyses. All percentages were calculated using the Proc
Surveymeans procedure in PC-SAS version 9.2 for data
collected using a complex survey design [55], and signifi-
cance was assessed based on overlap of the 95% confi-
dence intervals (CI) around the percentages. To assess
whether daily multivitamin, calciumD, and vitamin D
supplementation (none, from one source, or from ≥ 2
sources) patterns differed by race/ethnicity after adjust-
ing for age and educational attainment, we ran gender-
specific logistic regression models (Proc Surveylogistic)
with indicator variables to represent African-American/
Black (Black), Latino/a, Filipino/a, and Chinese com-
pared against nonHispanic Whites (WhiteNH) and con-
tinuous variables for age (5 year intervals) and education
(≤ high school graduate, some college, college graduate).
Confidence intervals for percentages in Tables 1, 2, 3
and Figures 1-2 and the adjusted odds ratios and CIs
from the logistic regression models that are not pre-
sented in the paper are available upon request.
Results
Table 1 presents characteristics of the women and men
by age group and race-ethnicity within age group. The
average ages of the younger and older groups were 37.7
yrs and 63 yrs, respectively. Within each age group, the
average age of WhiteNH and Black women and men
tended to be higher than that for the Latino/as, Filipino/
as, and Chinese, but most of the differences were not
statistically significant. Blacks and Latinos were signifi-
cantly less likely than nonHispanic Whites to be college
graduates and to have household incomes > $100,000.
Among women, Blacks and Latinas were significantly
less likely than WhiteNH, Filipinas, and Chinese to re-
port being in good health and significantly more likely to
be obese. Black women in both the younger and older
age groups had a significantly higher prevalence of dia-
betes and hypertension than WhiteNH women, and
among women aged > 50, Latinas and Filipinas also had
a higher prevalence of diabetes. While differences in
health-related characteristics among men in the five
race-ethic groups were very similar to those among the
women, due to smaller sample sizes, fewer comparisons
achieved statistical significance.
Table 1 Characteristics of Study Sample
Women Ages 25–50 yr Women ages 51–85 yr
All WhiteNH Black Latina Filipina Chinese All WhiteNH Black Latino Filipino Chinese
(N=3531) (N=1830) (N=263) (N=541) (N=282) (N=212) (N=5353) (N=3806) (N=376) (N=389) (N=271) (N=192)
Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd.% Wtd. %
Age (mean yrs) 37.8 38.5 37.9 37.4* 37.3 37.0 62.7 63.4 61.6* 60.9* 60.3* 60.9*
Race/Ethnicity
White nonHispanic 52.5 – – – – – 70.3 – – – – –
Black 7.0 – – – – – 6.4 – – – – –
Hispanic/Latina 15.5 – – – – – 7.4 – – – – –
Filipina 7.6 – – – – – 5.4 – – – – –
Chinese 5.6 – – – – – 3.8 – – – – –
Other Asian/Pac Isl. 9.0 – – – – – 4.6 – – – – –




13.2 11.1 17.4 24.8* 7.0 4.8 25.1 23.7 26.6 45.6* 17.9 18.1
Some College 36.5 36.3 48.0 43.8 32.5 15.7 38.4 39.4 51.8 35.6 21.8 36.7
College Graduate 50.3 52.6 34.6* 31.4* 60.5 79.5 36.5 36.9 21.6* 18.8* 60.2 45.2
Income (2007)
< $35,000 13.8 12.1 23.1* 16.6 14.0 6.9* 26.0 23.9 40.6* 37.1* 33.8* 14.1
$35,000-$50,000 14.0 11.2 20.9 21.1 16.1 11.5 14.8 14.9 16.9 14.3 12.4 14.9
50,001-$80,000 26.0 26.4 32.0 27.0 25.0 20.4 24.8 25.3 21.9 24.9 21.8 26.2
$80,001-$100,000 14.1 14.9 5.6 15.3 15.5 9.0 12.2 12.3 10.2 11.1 13.8 15.1
> $100,000 32.1 35.4 18.4* 20.0* 29.4 52.2* 22.2 23.6 10.4* 12.6* 18.2 29.7
Health Status
Good or better health 92.8 93.8 88.1* 89.7* 93.6 96.3 85.1 86.5 77.4* 78.2* 83.0 90.8
Diabetic 4.1 3.5 5.9* 5.2 9.1 2.0 12.9 10.5 24.0* 20.1* 20.9* 9.4
Hypertensive 10.2 9.8 16.3* 8.6 17.7* 6.8 46.4 44.8 64.8* 45.4 57.4* 38.0
Obese (BMI ≥ 30) 25.8 26.0 41.3* 34.9* 16.8* 7.2* 27.7 28.0 47.0* 39.3* 8.9* 9.1*
Age (mean yrs) 37.8 38.5 37.9 37.4* 37.2 37.0 62.7 63.4 61.6* 60.9* 60.3* 62.7
Race/Ethnicity
White nonHispanic 53.0 – – – – – 70.1 – – – – –
Black 5.7 – – – – – 5.2
Hispanic/Latino 15.6 – – – – – 8.2
Filipino 7.3 – – – – – 5.5
Chinese 6.0 – – – – – 3.6
Other Asian/Pac. Isl. 9.9 – – – – – 5.1




17.9 16.9 23.7 31.9* 13.9 3.7 21.2 19.9 23.7 35.0* 16.0 16.2
Some College 34.4 35.2 46.0 37.7 34.3 17.2 36.3 36.8 44.7 38.0 35.7 19.6
College Graduate 47.7 47.9 30.3* 30.4* 51.8 79.1* 42.5 43.3 31.6* 27.0* 48.3 64.2
Income (2007)
< $35,000 10.4 9.0 17.0 11.3 10.3 3.9 17.3 15.0 22.4 24.3* 25.2* 13.7
$35,000-$50,000 12.6 10.3 15.5 22.1 13.3 5.0 13.6 13.2 14.6 11.8 14.5 19.6
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Table 1 Characteristics of Study Sample (Continued)
$50,001-$80,000 27.2 26.5 32.3 30.6 33.6 26.6 24.4 24.3 24.2 30.4 22.9 17.5
$80,000-$100,000 14.5 15.0 11.3 13.1 12.3 16.3 13.3 14.2 12.6 10.5 14.5 10.2
> $100,000 35.3 39.2 23.9* 22.9* 30.5 48.2 31.4 33.3 26.2 23.0* 22.9* 39.0
Health Status
Good or better health 93.7 94.4 89.1* 93.3 93.0 96.5 83.7 83.9 79.8 82.0 85.7 87.4
Diabetic 4.3 2.9 10.6* 5.3 6.2 2.3 17.8 15.2 25.5* 26.8* 31.0* 16.2
Hypertensive 13.2 12.1 20.4 13.2 22.0* 7.8 49.9 48.3 64.2* 51.1 61.4 41.3
Obese (BMI ≥ 30) 25.1 25.7 34.5 34.2 18.2 9.8 26.4 27.3 31.1 39.3* 17.2* 2.8*
Wtd. %=Respondent data weighted to the age, gender, and geographic composition of the health plan membership at time of the survey. WhiteNH=nonHispanic
White; Pac. Isl, = Pacific Islander.
* Differs significantly from nonHispanic Whites at p<.05.
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by gender, age group, and race/ethnicity is shown in Fig-
ure 1 and Table 1. Among 25–50 year olds, 40% (CI:
38.3%-41.8%) of women and 54% (CI: 51.4%-56.2%) of
men were getting no vitamin D from dietary supplements
and only 18% (CI: 17.0-19.8%) and 5% (CI: 4.2-6.2%), re-
spectively, were getting vitamin D from ≥ 2 sources.
Among 51–85 year olds, approximately 27% (CI: 25.2-
28.1%) of women and 46% (CI: 44.8-48.4%) of men were
getting no vitamin D from dietary supplements, while only
around 39% (CI: 37.2-40.3%) of women and 11% (CI: 10.3-
12.5%) of men were getting it from ≥ 2 sources. As this
figure also shows, the age and gender-related differences
in vitamin D supplementation were primarily due to sig-
nificantly greater use of calciumD by women over age 50.
As indicated in Figure 1-2 and Table 2, we also found
that within age groups, there were race/ethnic differences
in vitamin D supplementation practices. Across both age
groups, Black and Latina women were significantly less
likely than nonHispanic Whites to be getting any vitamin
D from dietary supplements, and in the age 25–50 group,
Filipinas were also significantly less likely than nonHispa-
nic Whites to be getting any vitamin D from supplements.
In both age groups, Black women were half as likely as
nonHispanic White women to be getting vitamin D from
≥ 2 sources. Filipinas in the younger age group and Lati-
nas in the older age group were also significantly less likely
than nonHispanic White women to be getting vitamin D
from ≥ 2 sources. The prevalence of vitamin D supple-
mentation practices among Chinese women did not sig-
nificantly differ from that of nonHispanic White women
except for the percentages of women getting their vitamin
D from calciumD. Among men, in both age groups Lati-
nos were significantly less likely than nonHispanic Whites
to be getting any vitamin D from supplements, with Black
and Chinese men also less likely to be getting vitamin D
from supplements among those over the age of 50. There
were no significant race-ethnic differences in percentages
getting vitamin D from ≥ 2 supplement sources. All of the
significant differences based on percentage estimatesremained statistically significant in gender-specific models
that adjusted for age and education.
Vitamin D supplementation patterns of women and
men in the obese, diabetic, and hypertensive groups are
shown in Table 3. Among obese adults, 40% (CI: 37.8-
42.5%) of women and 51% (CI: 48.1-54.3%) of men were
getting no vitamin D from dietary supplements, and only
23% (CI: 21.1-25.0%) of women and 7% (CI: 5.7-8.8%) of
men were getting it from ≥ 2 sources. After adjusting for
age and race-ethnicity, obese women were significantly
more likely than non-obese women to get no vitamin D
from supplements (OR=1.45, CI: 1.28-1.63), with no sig-
nificant gender difference among men. Among diabetics,
37% (CI: 33.3-41.2%) of women and 49% (CI: 45.4-53.5%)
of men were getting no vitamin D from any dietary sup-
plement, and only 26% (CI: 22.9-30.1%) of women and 9%
(CI: 7.0-11.8%) of men were getting it from ≥ 2 supple-
ment sources. Prevalence of supplementation among
hypertensives was similar to that of diabetics, likely due in
part to overlap in these chronic condition groups. After
adjusting for race-ethnicity, women ≥ 51 with diabetes
and/or hypertension were at slightly higher risk than those
who did not have either condition to be getting no vitamin
D from supplements (OR=1.17, CI: 1.01-1.35), with no
significant difference among men.
Among obese, diabetic, and hypertensive women, Blacks
and Latinas were significantly more likely than nonHispa-
nic Whites to get no vitamin D from dietary supplements
(for Blacks and Latinas, respectively, after adjusting for
age: Obese: OR=1.69, CI: 1.25-2.30 and OR=2.14, 1.62-
2.84; Diabetic: OR=1.90, CI: 1.11-3.27 and OR=2.50, CI:
1.51-4.12; Hypertensive: OR=1.52, CI: 1.12-2.07 and
OR=1.57, CI: 1.12-2.22). Vitamin D supplementation
among Filipinas with hypertension was also significantly
lower than that among nonHispanic Whites (OR=1.44, CI:
1.01-2.04). Among obese, diabetic, and hypertensive men,
Latinos were significantly less likely than nonHispanic
Whites to be getting vitamin D from supplements (Obese:
OR=1.57, CI: 1.08-2.27; Diabetic: OR=1.73, CI: 1.04-2.90;
Hypertensive: OR=1.61, CI: 1.12-2.32).
Table 2 Percentages of adults taking a multivitamin, calcium, and getting vitamin D from supplements in 2008 by age
group, gender and race/ethnicity
Vitamin D from a Supplement1
Daily Multivitamin Calcium+D Supplement None From 1 source From ≥ 2 sources
Unwtd. N Wtd % Wtd. % Wtd. % Wtd. % Wtd. %
WOMEN
25-50 yr 3531 54.6 23.7 40.0 41.6 18.4
51-70 yr 3116 60.2 51.3 26.9 34.3 38.8
71-85 yr 2237 58.4 54.3 25.7 35.5 38.8
Age 25-50
WhiteNH 1832 60.8 24.4 34.7 45.3 20.0
Black 263 45.6* 17.4 47.8* 41.4 10.8*
Latina 541 48.7* 21.0 46.7* 36.8 16.5
Filipina 282 44.7* 18.9 49.6* 37.2 13.2*
Chinese 212 46.8* 34.1* 40.4 38.3 21.3
Age 51-85
WhiteNH 3806 61.2 53.3 25.7 33.7 40.6
Black 376 51.2* 33.4* 37.0* 41.1 21.9*
Latina 389 49.8* 41.4* 35.5* 37.7 26.8*
Filipina 271 59.4 57.0 23.3 37.0 39.7
Chinese 192 58.1 61.5 22.3 35.6 42.1
MEN
25-50 yr 2120 44.5 6.8 53.8 40.9 5.2
51-70 yr 2737 49.5 13.4 47.3 42.3 10.4
71-85 yr 2308 50.8 19.7 44.2 40.8 15.0
Age 25-50
WhiteNH 1127 48.4 6.1 50.1 45.1 4.8
Black 119 45.0 9.6 52.1 40.6 7.3
Latino 324 38.4* 6.8 60.9* 33.0 6.1
Filipino 153 50.3 6.9 47.0 48.8 4.2
Chinese 128 40.2 11.3 55.2 38.1 6.7
Age 51-85
WhiteNH 3646 52.9 14.7 43.8 45.2 11.4
Black 285 43.7 12.2 54.2* 35.1 10.7
Latino 371 37.8* 11.8 58.5* 56.5 8.0
Filipino 233 47.8 17.9 45.7 41.6 12.7
Chinese 186 39.4* 15.3 57.1* 31.0 11.9
Unwtd. N = Actual subgroup sample size. Wtd. % = Respondent data weighted to the age, gender, and geographic composition of the health plan membership at
time of the survey.
1 Sources of vitamin D: Calcium with D, multivitamin, singular D, or D in another combination. At the time of the survey, each of these sources generally
contained 400 IU of vitamin D2.
* Differs significantly from White nonHispanics at p<.05.
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Due to many factors, (e.g., decrease in non-protected sun
exposure, decreased consumption of vitamin D fortified
foods, changing racial and age composition of the popula-
tion, and increase in percentage of adults unable to use
vitamin D efficiently due to advanced age, obesity,medication use, medical treatments, and health conditions),
the prevalence of vitamin D insufficiency and deficiency in
the population is increasing [32-34,40,45]. Based on our
survey, we estimate that 40% of women aged 25–50, over
25% of women aged 51–85, and approximately 50% of men
in both age groups in a relatively well-educated, insured
Table 3 Vitamin D supplementation by men and women
aged 25–85 in selected health risk groups
Number of Vitamin D Sources 1
Unwtd None 1 Source ≥ 2 Sources
N Wtd. % Wtd. % Wtd. %
Obese (BMI ≥30)2
Women
All 2324 40.2 36.8 23.0
WhiteNH 1463 34.4 38.9 26.7
Black 290 47.4* 39.4 12.9*
Latino 333 55.0* 29.9 15.1*
Men
All 1707 51.2 41.5 7.3
WhiteNH 1164 47.9 44.9 7.1
Black 131 49.0 41.4 9.5
Latino 234 60.2* 32.7 7.1
Diabetic 2
Women
All 885 37.3 36.2 26.5
WhiteNH 490 30.9 38.5 30.5
Black 108 48.0* 41.6 12.4*
Latino 121 54.1* 27.5 18.4*
Men
All 1125 49.4 41.2 9.4
WhiteNH 685 45.3 44.0 10.6
Black 96 50.4 36.1 13.5
Latino 129 60.3* 37.5 2.2*
Hypertensive
Women
All 3169 33.0 36.6 32.0
WhiteNH 2094 28.8 35.8 35.3
Black 316 39.4* 44.0 16.6*
Latino 252 41.5* 34.5 24.0*
Filipino 225 39.7* 35.5 24.8*
Chinese 101 29.5 32.7 37.7
Men
All 3091 46.7 43.4 9.9
WhiteNH 2099 43.9 46.0 10.1
Black 241 47.1 44.3 8.6
Latino 246 56.3* 33.2 10.5
Filipino 183 46.0 44.2 9.8
Chinese 112 52.5 37.6 9.9
Unwtd. N = Actual subgroup sample size. Wtd. % = Respondent data
weighted to the age, gender, and geographic composition of the health plan
membership at time of the survey.
1 Sources of vitamin D: Calcium with D, multivitamin, singular D, or D in
another combination. At the time of the survey, each of these sources
generally contained contained 400 IU of vitamin D2.
2 Numbers of Filipino and Chinese women and men in risk group too small to
use for estimates.
* Differs significantly from White nonHispanics at p<.05.
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http://www.nutritionj.com/content/11/1/104health plan population are getting no vitamin D from any
dietary supplementation. This suggests that the substantial
portion of adults who are not getting adequate vitamin D
from sun exposure and fortified food sources to meet the
IOM’s current RDA for vitamin D are unlikely to be mak-
ing up the difference with vitamin D supplements. Age-
and gender-related differences in vitamin D supplementa-
tion were primarily due to differences in use of calcium
with D supplements.
Similar to the NHANES-based findings of race-ethnic
differences in calcium and multivitamin supplement use
[50,51], we found that Black and Latina women in the
25–50 and over 50 age groups and Black and Latino men
over the age of 50 were significantly less likely than non-
Hispanic Whites to be getting any vitamin D from dietary
supplements. This is of clinical and public health concern
because of the documented high prevalence of vitamin D
deficiency in Black and Latino populations [33,34].
Because the results of epidemiologic studies of risks
associated with vitamin D deficiency will continue to
reach the public a long time before definitive recom-
mendations based on clinical trial results are available,
manufacturers of multivitamins, calcium with D supple-
ments, and singular vitamin D, as well as producers of
foods that are fortified with vitamin D, need guidance
about the appropriate dosage of vitamin D to put into
these types of supplements. Also, because manufacturers
are likely to increase the amount of vitamin D and
calcium in their multivitamin and calcium supplements
based on the new IOM recommendations, people who
have been taking both a daily multivitamin and calcium
with D supplement may suddenly find that they are
exceeding the recommended intake, although evidence
suggests that dosages as high as 4,000 IU/day are not
toxic [42]. In the short term, serum 25-hydroxyvitamin
D (25[OH]D) samples from the most recent cycle of
NHANES could be analyzed separately for males and
females in different age and race-ethnic groups and for
these groups by different parts of the U.S to determine
extent of variation in vitamin D insufficiency and defi-
ciency. This information about the general population
could then be augmented by clinical studies to deter-
mine how high a dose of vitamin D3 is required to bring
D-insufficient and D-deficient people up to what is
considered adequate levels, resulting in more tailored
DRIs for vitamin D based not only on age, but also
race-ethnicity, season, and geographic location.
Our study has several limitations. First, because the
overall survey response rate to this general health survey
was under 50%, there is a possibility that response bias
might limit the accuracy of the results. However, previous
studies have found that respondents to self-administered
surveys are more likely to be better educated than nonre-
spondents, and because numerous studies have found that
5.3
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Ages 25-50 Ages 51-85 
59.9 73.3 65.3 52.2 50.4 59.6     74.3    63.0 64.5 77.753.3 76.6
Figure 1 Percentages of Women Who Got Vitamin D from a Calcium+D and/or a Daily Multivitamin Supplement, by Age and Race/Ethnicity,
2008. Note: Less than .2% of 25–51 year olds and less than .5% of 51–85 year olds got vitamin D supplementation from another source in 2008.
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http://www.nutritionj.com/content/11/1/104health promoting behaviors are more prevalent among
better educated adults, any response bias would likely re-
sult in our findings over-estimating the prevalence of vita-
min D supplementation in the general population.
Another limitation of the study sample is that the
numbers of Blacks, Latinos, Filipinos, and Chinese
respondents used to estimate vitamin D supplementa-
tion in different race-ethnic groups were relatively small
after being split across the four age-gender groups. This
resulted in relatively wide confidence intervals around
the estimated prevalence of supplement use. However,
we obtained the same results with narrower confidence
intervals in preliminary analyses using a sample of
pooled 2005 and 2008 member survey respondents with
nearly double the size of all the race-ethnic subgroups.
The reason we decided to restrict our analyses to the
2008 survey was that the 2005 survey did not enable us
to differentiate people who used calcium with D vs.1.6 3.5 1.3 2.9 0.7 2.7




















































46.1 53.3 55.7 47.9 53.039.1
Figure 2 Percentages of Men Who Got Vitamin D from a Calcium+D a
Ethnicity, 2008. Note: Less than 0.2% of 25–51 year olds and less than 0.5
source in 2008.calcium without D. Because the nonHispanic White
subgroup was relatively large, we had sufficient power to
identify several statistically significant race-ethnic differ-
ences in vitamin D supplementation.
A different type of limitation resulted from assump-
tions we could make about vitamin D intake from sup-
plements. We could only estimate number of sources of
vitamin D based on indication of taking multivitamins,
calcium with D tablets, and singular vitamin D, not actual
vitamin D intake as relates to IOM recommendations.
While the normative amount of vitamin D in an adult
multivitamin and calcium with D tablet in 2007–2008
was 400 IU, we do not know whether people taking
calcium with D took one tablet (400 IU) or two (800 IU).
Also, our estimates of the percentages of women and
men getting vitamin D from ≥ 2 sources was based on
the assumption that people who were taking calcium and
multivitamins were doing so daily. However, when we4.6 3.3 1.8 3.8 6.6 3.5































 and Multivitamin Multivitamin Only
Ages 51-85 
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nd/or a Daily Multivitamin Supplement, by Age and Race/
% of 51–85 year olds got vitamin D supplementation from another
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from a separate 2008 survey of members of the same
health plan to test that assumption, we found that it did
not hold (unpublished data). Among those who reported
using both calcium and multivitamin supplements, only
45% of women and 32% of men aged 25–49, 68% of
women and 55% of men aged 50–69, and 80% of women
and 68% of men aged 70–84 were using both of these
supplements on a daily basis, and only about 5-7% more
were using both supplements at least five times a week.
We also found that across both age groups, Black, Latino,
and Filipino men and women users of both calcium and
multivitamin supplements were significantly less likely
than nonHispanic Whites to take both of them daily or at
least five times a week. This suggests that our study results
actually overestimates the percentages of adults who were
getting vitamin D daily from at least one source, and that
the extent of race-ethnic differences in vitamin D supple-
mentation is probably underestimated.
A final limitation of our study is that we could not place
vitamin D supplementation in the context of the extent
to which individual respondents were in need of
vitamin D from supplements based on their serum 25-
hydroxyvitamin D (25[OH]D) concentration and amount
of vitamin D they were getting from sun exposure and
food intake. The survey did not include dietary recall data
to enable analysis of potential vitamin D availability from
food sources, nor did it ask about sun exposure practices.
At the time of the survey, serum vitamin D tests were not
routinely done, limiting the number of survey respondents
for whom serum vitamin D status data would have been
available. However, a recent national survey found that
over 70% of nonHispanic White adults and nearly all
Black and Latino adults in the U.S. were vitamin D insuffi-
cient [44]. Further, the aim of this study was to examine
patterns of vitamin D intake from dietary supplements,
not vitamin D intake from all sources nor the extent to
which supplementation was actually desirable.
Conclusion
Our study results suggest that a large percentage of adults
do not get vitamin D from dietary supplements and that
absence of supplementation is common among young
women and men, older men, and people who are obese.
Further, Blacks and Latinos, who are at elevated risk for
vitamin D insufficiency due to darker skin pigmentation,
are less likely to get vitamin D from dietary supplements
than similarly aged nonHispanic Whites. Randomized
clinical trials are needed to clarify the benefits and risks
of vitamin D supplementation at various dosages for
many of the health problems that have been linked to
vitamin D deficiency by observational studies. If vitamin
D is demonstrated to be efficacious in reducing chronic
diseases, vitamin D supplementation may be an easy andinexpensive way to help reduce some race-ethnic health
disparities and to contain burgeoning health care costs
due to increasing prevalence of chronic diseases. However,
until large-scale randomized clinical trials such as the
VITAL study [56] clarify whether or not vitamin D intakes
higher than those recommended in the recent IOM report
would be beneficial, the public should at a minimum be
advised about how to meet current IOM recommenda-
tions for vitamin D intake either through diet or vitamin
supplementation and provision of public health screening
programs for population subgroups at high-risk for vita-
min D deficiency considered.
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